Skip to main content
Explore URMC


Majed A. Refaai, M.D.


Contact Information

Phone Numbers

Fax: (585) 273-3003

Office: (585) 276-3927

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients


Dr. Refaai's clinical service is in Transfusion Medicine with subspecialty involvement in laboratory coagulation/thrombosis testing.


Dr. Refaai's recent studies have included: The in-vitro effect of ABO anti-bodies on platelet function; The correlation between cancer and tissue factor (TF) plasma concentrations and its role in developing DVT; The relationship between the circulating TF and the cancer tissue concentrations of TF in different types of mouse models; Beriplex phase IIIb drug study for bleeding patients with Warfarin overdose; Beriplex phase IIIb drug study for surgical patients who require a quick reversal of Warfarin; The effect of ABO non-identical blood products transfusion on platelet function (in-vivo); Platelet transfusion in patients with positive heparin-induced thrombocytopenia; Comparison of tissue factor pathway inhibitor (TFPI) concentration and activity in mononuclear cells from normal individuals versus patients with Paroxysmal Nocturnal Hemoglobinuria; Comparison of TFPI concentrations in normal mouse plasma and endothelial cells versus a diabetic mouse model; Analysis of fatty acid ethyl ester (FAEE) concentrations in binge drinking, chronic alcoholics, and postmortem biopsies.


Faculty Appointments


  • Clinical Pathology/Laboratory Medicine - American Board of Pathology


MD | Syria - Aleppo Univ School of Medicine, Aleppo

Post-doctoral Training & Residency

04/01/1997 - 05/31/2003
Research in at Massachusetts General Hospital

06/30/2003 - 06/30/2006
Residency in Pathology-Anatomic and Clinical at Barnes-Jewish Hospitals

07/01/2006 - 06/30/2007
Fellowship in Transfusion Medicine at University of Texas Southwestern Medical Center

VIEW ALL expand_more


Journal Articles

Farnsworth CW, Schott EM, Jensen SE, Zukoski J, Benvie AM, Refaai MA, Kates SL, Schwarz EM, Zuscik MJ, Gill SR, Mooney RA. "Adaptive upregulation of Clumping Factor A (ClfA) by S. aureus in the obese, type 2 diabetic host mediates increased virulence." Infection and immunity.. 2017 Mar 20; Epub 2017 Mar 20.

Agostini-Vulaj D, Francis CW, Refaai MA. "Management of concomitant factor VII deficiency and Factor V Leiden mutation." International journal of laboratory hematology.. 2017 Feb 0; 39(1):e10-e13.

Greener D, Henrichs KF, Liesveld JL, Heal JM, Aquina CT, Phillips GL, Kirkley SA, Milner LA, Refaai MA, Mendler JH, Szydlowski J, Masel D, Schmidt A, Boscoe FP, Schymura MJ, Blumberg N. "Improved outcomes in acute myeloid leukemia patients treated with washed transfusions." American journal of hematology.. 2017 Jan 0; 92(1):E8-E9.